Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WHO Grade 4 Glioma”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Very early researchActive Not RecruitingNCT05182905
What this trial is testing

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

Who this might be right for
GlioblastomaGliomaGlioblastoma Multiforme+1 more
Nader Sanai 97
Not applicableAvailableNCT02146066
What this trial is testing

Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Who this might be right for
GBMGlioblastoma Multiforme
Northwest Biotherapeutics
Early research (Phase 1)Ended earlyNCT03246113
What this trial is testing

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

Who this might be right for
Glioblastoma
New York State Psychiatric Institute 1
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Early research (Phase 1)Not Yet RecruitingNCT07385846
What this trial is testing

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

Who this might be right for
GlioblastomaMismatch Repair Deficiency
Jennifer Leddon 8
Testing effectiveness (Phase 2)Study completedNCT00104091
What this trial is testing

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 56
Not applicableActive Not RecruitingNCT07832448
What this trial is testing

Microsurgical Resection Combined With Photodynamic Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)
Yonggao Mou 10
Testing effectiveness (Phase 2)Looking for participantsNCT06160206
What this trial is testing

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaRecurrent WHO Grade 4 Glioma
Academic and Community Cancer Research United 134
Early research (Phase 1)Ended earlyNCT00272870
What this trial is testing

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Who this might be right for
Glioblastoma Multiforme (WHO Grade IV)Anaplastic Astrocytoma (WHO Grade III)
Children's Hospital Medical Center, Cincinnati 1
Large-scale testing (Phase 3)Looking for participantsNCT06160492
What this trial is testing

Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)

Who this might be right for
5-aminolevulinic AcidFluorescence-guided Resection
Lee's Pharmaceutical Limited 144
Testing effectiveness (Phase 2)UnknownNCT01903330
What this trial is testing

ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcoma
Epitopoietic Research Corporation 84
Very early researchNot Yet RecruitingNCT07778602
What this trial is testing

Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)IDH Wildtype Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Not applicableNot Yet RecruitingNCT06845020
What this trial is testing

CSF Proteomic Characterization of Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma WHO Grade IVGlioblastoma (GBM)+2 more
Univeridad Autonoma de Guadalajara 15
Testing effectiveness (Phase 2)Ended earlyNCT04915404
What this trial is testing

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Who this might be right for
Recurrent Glioblastoma Multiforme
WPD Pharmaceuticals Sp. z o.o. 5
Testing effectiveness (Phase 2)Study completedNCT00813943
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Who this might be right for
Glioblastoma
EMD Serono 265
Early research (Phase 1)Study completedNCT03615404
What this trial is testing

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

Who this might be right for
GlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more
Gary Archer Ph.D. 11
Not applicableLooking for participantsNCT07091864
What this trial is testing

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeWHO Grade 4 Glioma
Mayo Clinic 116
Not applicableWithdrawnNCT03956706
What this trial is testing

Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas

Who this might be right for
GlioblastomaAstrocytoma, Grade IIIAstrocytoma, Grade IV+1 more
Northwell Health
Early research (Phase 1)Study completedNCT01020292
What this trial is testing

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Who this might be right for
Glioma
Abramson Cancer Center at Penn Medicine 31
Next Page